Abstract P1-18-28: Phase IV Study Evaluating Effectiveness and Safety of Talazoparib in Patients with Locally Advanced or Metastatic HER2 Negative Breast Cancer and a BRCA1 or BRCA2 Mutation (Vital)
Cancer Research（2022）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined